Menglin Wu1, Liang Li1, Jiahui Wang1, Yanyan Zhang1, Qi Guo1, Xue Li2,3, Xuening Zhang4,5. 1. Radiology Department, Second Hospital of Tianjin Medical University, Tianjin, China. 2. Radiology Department, Second Hospital of Tianjin Medical University, Tianjin, China. lx_1229@163.com. 3. Department of Medical Imaging, Second Hospital of Tianjin Medical University, 23 Pingjiang Road, Hexi District, Tianjin, 300211, China. lx_1229@163.com. 4. Radiology Department, Second Hospital of Tianjin Medical University, Tianjin, China. luckyxn_tianjin@163.com. 5. Department of Medical Imaging, Second Hospital of Tianjin Medical University, 23 Pingjiang Road, Hexi District, Tianjin, 300211, China. luckyxn_tianjin@163.com.
Abstract
OBJECTIVES: This meta-analysis was performed to evaluate the accuracy of contrast-enhanced ultrasound (CEUS) in differentiating malignant from benign focal liver lesions (FLLs). METHODS: Cochrane Library, PubMed and Web of Science databases were systematically searched and checked for studies using CEUS in characterization of FLLs. Data necessary to construct 2×2 contingency tables were extracted from included studies. The QUADAS tool was utilized to assess the methodologic quality of the studies. Meta-analysis included data pooling, subgroup analyses, meta-regression and investigation of publication bias was comprehensively performed. RESULTS: Fifty-seven studies were included in this meta-analysis and the overall diagnostic accuracy in characterization of FLLs was as follows: pooled sensitivity, 0.92 (95%CI: 0.91-0.93); pooled specificity, 0.87 (95%CI: 0.86-0.88); diagnostic odds ratio, 104.20 (95%CI: 70.42-154.16). Subgroup analysis indicated higher diagnostic accuracy of the second-generation contrast agents (CAs) than the first-generation CA (Levovist; DOR: 118.27 vs. 62.78). Furthermore, Sonazoid demonstrated the highest diagnostic accuracy among three major CAs (SonoVue, Levovist and Sonazoid; DOR: 118.82 vs. 62.78 vs. 227.39). No potential publication bias was observed of the included studies. CONCLUSION: CEUS is an accurate tool to stratify the risk of malignancy in FLLs. The second-generation CAs, especially Sonazoid may greatly improve diagnostic performance. KEY POINTS: • CEUS shows excellent diagnostic accuracy in differentiating malignant from benign FLLs. • The second-generation CAs have higher diagnostic accuracy than first-generation CAs. • Sonazoid demonstrates the highest diagnostic accuracy among three major CAs.
OBJECTIVES: This meta-analysis was performed to evaluate the accuracy of contrast-enhanced ultrasound (CEUS) in differentiating malignant from benign focal liver lesions (FLLs). METHODS: Cochrane Library, PubMed and Web of Science databases were systematically searched and checked for studies using CEUS in characterization of FLLs. Data necessary to construct 2×2 contingency tables were extracted from included studies. The QUADAS tool was utilized to assess the methodologic quality of the studies. Meta-analysis included data pooling, subgroup analyses, meta-regression and investigation of publication bias was comprehensively performed. RESULTS: Fifty-seven studies were included in this meta-analysis and the overall diagnostic accuracy in characterization of FLLs was as follows: pooled sensitivity, 0.92 (95%CI: 0.91-0.93); pooled specificity, 0.87 (95%CI: 0.86-0.88); diagnostic odds ratio, 104.20 (95%CI: 70.42-154.16). Subgroup analysis indicated higher diagnostic accuracy of the second-generation contrast agents (CAs) than the first-generation CA (Levovist; DOR: 118.27 vs. 62.78). Furthermore, Sonazoid demonstrated the highest diagnostic accuracy among three major CAs (SonoVue, Levovist and Sonazoid; DOR: 118.82 vs. 62.78 vs. 227.39). No potential publication bias was observed of the included studies. CONCLUSION: CEUS is an accurate tool to stratify the risk of malignancy in FLLs. The second-generation CAs, especially Sonazoid may greatly improve diagnostic performance. KEY POINTS: • CEUS shows excellent diagnostic accuracy in differentiating malignant from benign FLLs. • The second-generation CAs have higher diagnostic accuracy than first-generation CAs. • Sonazoid demonstrates the highest diagnostic accuracy among three major CAs.
Authors: Ilias Gatos; Stavros Tsantis; Stavros Spiliopoulos; Aikaterini Skouroliakou; Ioannis Theotokas; Pavlos Zoumpoulis; John D Hazle; George C Kagadis Journal: Med Phys Date: 2015-07 Impact factor: 4.071
Authors: D Strobel; K Seitz; W Blank; A Schuler; C Dietrich; A von Herbay; M Friedrich-Rust; G Kunze; D Becker; U Will; W Kratzer; F W Albert; C Pachmann; K Dirks; H Strunk; C Greis; T Bernatik Journal: Ultraschall Med Date: 2008-10 Impact factor: 6.548
Authors: E M Jung; D A Clevert; A G Schreyer; S Schmitt; J Rennert; R Kubale; S Feuerbach; F Jung Journal: World J Gastroenterol Date: 2007-12-21 Impact factor: 5.742
Authors: F Giangregorio; M Garolfi; E Mosconi; L Ricevuti; M G Debellis; M Mendozza; C Esposito; E Vigotti; D Cadei; D Abruzzese Journal: J Ultrasound Date: 2022-10-13
Authors: Jun Li; Ming Chen; Zi-Jing Wang; Shu-Gang Li; Meng Jiang; Long Shi; Chun-Li Cao; Tian Sang; Xin-Wu Cui; Christoph F Dietrich Journal: World J Clin Cases Date: 2020-11-26 Impact factor: 1.337